arrow
N

Namita Goyal

university of california—irvine
H指数:36
被引数:5,927

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis

作者更正: 肌萎缩性侧索硬化症对C9orf72蛋白的自身免疫反应

Nature
IF48.5
2026-03-180
OAAI
Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the Immune Regulator NP001 Suggests an Immunopathogenic Subset of ALS

以免疫调节剂NP001治疗缓慢进展型肌萎缩侧索硬化症(ALS)患者时,对15%肺活量丧失时间和生存期延长的定量测量表明存在一种免疫病理亚型ALS。

2025-12-120
OAAI
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral Sclerosis

多中心扩展性访问方案:通过向肌萎缩侧索硬化症患者提供海藻糖进行研究

2025-08-260
OAAI
Trial of Intravenous Immune Globulin in Dermatomyositis
2022-10-0680
OA
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
2022-05-1651
OAAI
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis Long-term Extension of RESILIENT
2021-03-2330
OA
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
2020-09-03345
OAAI
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis
2016-07-0590
OAAI